Heerma Peter — SEC insider filings

SEC reporting owner CIK 1789617. 28 insider filings on record with FilingPulse; latest filed 2026-09-17.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-10-05 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Travere Therapeutics, Inc. (TVTX)EVP, CHIEF COMMERCIAL OFFICER28—35 legs · 359,908 sh · $19,896,87942

Insider filings — Heerma Peter

FiledFormIssuerReported transactionsSource
2026-09-174Travere Therapeutics, Inc. (TVTX)Option exercise (M): 39,283 @ $26.88 · Option exercise (M): 1,381 @ $22.40 · Option exercise (M): 36,526 @ $8.93 · Sale (S): 71,938 @ $62.05 · Sale (S): 27,421 @ $62.59 · Sale (S): 1,400 @ $63.65 · +15 moreEDGAR
2026-05-064Travere Therapeutics, Inc. (TVTX)Option exercise (M): 4,250 @ $0 · Sale (S): 2,174 @ $46.65 · Grant/award (A): 8,500 (derivative) @ $0 · Option exercise (M): 4,250 (derivative) @ $0EDGAR
2026-04-154Travere Therapeutics, Inc. (TVTX)Grant/award (A): 14,000 @ $0 · Sale (S): 7,215 @ $41.93EDGAR
2026-02-034Travere Therapeutics, Inc. (TVTX)Grant/award (A): 26,120 @ $0 · Sale (S): 7,310 @ $32.12 · Grant/award (A): 69,640 (derivative) @ $0EDGAR
2025-12-294Travere Therapeutics, Inc. (TVTX)Sale (S): 4,980 @ $40EDGAR
2025-11-044Travere Therapeutics, Inc. (TVTX)Sale (S): 5,591 @ $35 · Gift (G): 1,078 @ $0EDGAR
2025-10-304Travere Therapeutics, Inc. (TVTX)Sale (S): 2,662 @ $30EDGAR
2025-09-244Travere Therapeutics, Inc. (TVTX)Gift (G): 891 @ $0EDGAR
2025-05-054Travere Therapeutics, Inc. (TVTX)Option exercise (M): 4,920 · Sale (S): 1,771 @ $21.05 · Option exercise (M): 4,920 (derivative) @ $0EDGAR
2025-02-124Travere Therapeutics, Inc. (TVTX)Option exercise (M): 8,000 · Sale (S): 3,074 @ $25 · Sale (S): 2,568 @ $23.53 · Option exercise (M): 8,000 (derivative) @ $0EDGAR
2025-02-044Travere Therapeutics, Inc. (TVTX)Grant/award (A): 21,500 @ $0 · Sale (S): 5,166 @ $20.12 · Grant/award (A): 58,000 (derivative) @ $0EDGAR
2025-01-234Travere Therapeutics, Inc. (TVTX)Sale (S): 1,584 @ $18.94EDGAR
2024-09-094Travere Therapeutics, Inc. (TVTX)Grant/award (A): 6,750 @ $0 · Sale (S): 2,191 @ $11.52EDGAR
2024-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 25,000 @ $0 · Sale (S): 4,195 @ $8.53 · Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-01-254Travere Therapeutics, Inc. (TVTX)Sale (S): 1,559 @ $9.07EDGAR
2023-10-044Travere Therapeutics, Inc. (TVTX)Sale (S): 3,091 @ $8.25EDGAR
2023-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 20,250 @ $0 · Sale (S): 1,779 @ $21.75 · Grant/award (A): 54,500 (derivative) @ $0 · Grant/award (A): 6,750 (derivative) @ $0EDGAR
2023-01-264Travere Therapeutics, Inc. (TVTX)Sale (S): 1,550 @ $21.90EDGAR
2022-10-064Travere Therapeutics, Inc. (TVTX)Sale (S): 3,042 @ $25.68EDGAR
2022-02-024Travere Therapeutics, Inc. (TVTX)Grant/award (A): 9,840 @ $0 · Sale (S): 1,125 @ $27.40 · Grant/award (A): 39,360 (derivative) @ $0 · Grant/award (A): 9,840 (derivative) @ $0 · Grant/award (A): 8,000 (derivative) @ $0EDGAR
2022-01-264Travere Therapeutics, Inc. (TVTX)Sale (S): 1,875 @ $24.98EDGAR
2021-10-054Travere Therapeutics, Inc. (TVTX)Sale (S): 3,058 @ $24.77EDGAR
2021-08-174Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,500 @ $0 · Sale (S): 1,407 @ $17.12EDGAR
2021-02-094Travere Therapeutics, Inc. (TVTX)Sale (S): 1,125 @ $31.41 · Sale (S): 1,125 @ $31.58EDGAR
2021-02-054Travere Therapeutics, Inc. (TVTX)Grant/award (A): 4,500 @ $0EDGAR
2021-02-034Travere Therapeutics, Inc. (TVTX)Sale (S): 563 @ $30.75 · Sale (S): 563 @ $28.91EDGAR
2021-01-254Travere Therapeutics, Inc. (TVTX)Grant/award (A): 15,000 @ $0 · Grant/award (A): 57,500 (derivative) @ $0EDGAR
2020-10-054Retrophin, Inc. (RTRX)Sale (S): 2,188 @ $18.90 · Sale (S): 2,188 @ $19.35EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789617 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs